State Street’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $37.6K | Hold |
|
|||||
|
2024
Q4 | $44.6K | Hold |
|
|||||
|
2024
Q3 | $30.3K | Hold |
|
|||||
|
2024
Q2 | $50.5K | Hold |
|
|||||
|
2024
Q1 | $538K | Sell |
|
|||||
|
2023
Q4 | $441K | Hold |
|
|||||
|
2023
Q3 | $280K | Hold |
|
|||||
|
2023
Q2 | $325K | Hold |
|
|||||
|
2023
Q1 | $235K | Buy |
|
|||||
|
2022
Q4 | $474K | Buy |
|
|||||
|
2022
Q3 | $82K | Hold |
|
|||||
|
2022
Q2 | $89K | Hold |
|
|||||
|
2022
Q1 | $170K | Buy |
|
|||||
|
2021
Q4 | $208K | Hold |
|
|||||
|
2021
Q3 | $316K | Hold |
|
|||||
|
2021
Q2 | $335K | Sell |
|
|||||
|
2021
Q1 | $1.97M | Sell |
|
|||||
|
2020
Q4 | $2.64M | Buy |
|
|||||
|
2020
Q3 | $2.06M | Buy |
|
|||||
|
2020
Q2 | $2.46M | Buy |
|
|||||
|
2020
Q1 | $1.42M | Sell |
|
|||||
|
2019
Q4 | $3.39M | Sell |
|
|||||
|
2019
Q3 | $2.87M | Sell |
|
|||||
|
2019
Q2 | $12.7M | Sell |
|
|||||
|
2019
Q1 | $13.7M | Sell |
|
|||||
|
2018
Q4 | $11.8M | Sell |
|
|||||
|
2018
Q3 | $25.3M | Sell |
|
|||||
|
2018
Q2 | $31.1M | Buy |
|
|||||
|
2018
Q1 | $27.5M | Buy |
|
|||||
|
2017
Q4 | $566K | Buy |
|
|||||
|
2017
Q3 | $358K | Buy |
|
|||||
|
2017
Q2 | $278K | Sell |
|
|||||
|
2017
Q1 | $745K | Buy |
|
|||||
|
2016
Q4 | $819K | Buy |
|
|||||
|
2016
Q3 | $934K | Buy |
|
|||||
|
2016
Q2 | $751K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $918K | Buy |
|